Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement

This study has been completed.
Information provided by (Responsible Party):
Jeffrey L Goldberg, Stanford University Identifier:
First received: August 2, 2011
Last updated: August 1, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)